ScienceDex / Researcher record
Chen, Swey-Shen
- Ige Therapeutics, Inc. (no department on record)
From the FY2009 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2009
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2009 | $701,647 | 2 | #12,196 |
| 2010 | $702,036 | 2 | #12,401 |
| 2016 | $853,476 | 1 | #8,381 |
| 2017 | $1,669,820 | 2 | #3,482 |
| 2018 | $1,362,730 | 2 | #4,979 |
| 2019 | $982,439 | 1 | #8,418 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2009 · selected2 records
- FY20102 records
- FY20161 record
- FY20172 records
- FY20182 records
- FY20191 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2009 award records by amount
NIH award records listing Chen, Swey-Shen as a PI. Multi-PI records show the full award amount for context.
- 1R43AI084348-01R43Contact PITargeting Galectin-3 with novel drugs for treatment of eczema$401.6Kaward amount
- $300Kaward amount
Award organization
Organizations that administered FY2009 awards listing Chen, Swey-Shen as a PI.
FY2009 award administered by Ige Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardIge Therapeutics, Inc.
- 2009$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #8381
- 2017Entered Top 25% NationallyRanked #3482
- 2018$5M Cumulative Funding